Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein CROC-4 (also known as C1orf61 or "contingent replication of cDNA 4") is a nuclear protein encoded by the C1orf61 gene, which also serves as the host gene for the primary transcript of miR-9-1, one of the three genes encoding the microRNA miR-9 in humans. The CROC-4 protein acts as a transcriptional activator, particularly of the c-fos proto-oncogene promoter, and is believed to be involved in neuronal development and cellular plasticity, especially during brain formation. Expression of CROC-4/miR-9-1 is highly tissue-specific and is tightly correlated with proliferating and migrating cells in the developing brain. The miR-9-1/CROC-4 locus is induced by inflammatory signals, including lipopolysaccharide (LPS) and TNF-α, via NF-κB-dependent activation, serving a key role in the innate immune response by regulating NF-κB signaling through miR-9. miR-9 has additional roles in neuronal function, insulin-producing cell regulation, and cancer pathogenesis. However, Protein CROC-4 itself is not a typical drug target or therapeutic receptor, and no specific drugs or direct mechanisms of action involving this protein are currently established. Note: This entry is not a canonical therapeutic target but rather a host gene for a regulatory microRNA. The primary biological relevance for drug discovery relates to the microRNA (miR-9) it encodes and regulates, rather than CROC-4 as a standalone protein. If searching for therapeutic targeting, focus should be shifted to *miR-9* or its downstream pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein CROC-4 (CROC-4).